Genetic Engineering & Biotechnology News

NOV1 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 8 of 57

Copyright © 2017 PerkinElmer, Inc. 400374_03 All rights reserved. PerkinElmer® is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners. Get the keys to unlock the next blockbuster immunotherapy Immuno-oncology is one of the most exciting new developments in cancer research. A deep understanding of important targets like PD-1 and PD-L1 could be the key to unlocking the next blockbuster immunotherapy, kickstarting the body's own immune response to fight cancer. Our Alpha Technology immunoassays are the perfect fit for that research, providing a broad range of reproducible, highly sensitive, no-wash solutions for high-throughput screening and biomarker validation, including ready-to-use kits, customizable toolbox reagents, and full custom assay development services. There's no work more important – and now you have the tools to move it forward. Learn more at ASSAYS FOR IMMUNO-ONCOLOGY RESEARCH THAT SUIT YOU TO A " T "

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - NOV1 2018